Identifying relevant factors influencing cancer-related fatigue in patients with diffuse large B-cell lymphoma during chemotherapy

Table 5 Univariate analysis of cancer-related fatigue in patients with diffuse large B-cell lymphoma

Influencing factors	Eligible, n = 62	Average PFS score	P value
Sex			0.543
Male	29	5.44 ± 2.32
Female	33	5.74 ± 2.20
Age in years			0.095
≤ 65	49	4.59 ± 1.25
> 65	13	5.15 ± 2.42
Marital status			0.206
Married	21	5.57 ± 2.34
Unmarried	40	5.95 ± 2.53
Others	1	6.54 ± 2.32
Education			0.390
High school or less	23	4.39 ± 1.60
College	20	4.37 ± 1.38
Bachelor’s degree	15	5.07 ± 2.21
Graduate degree	4	5.93 ± 2.52
Self-efficacy level	26		0.031
High	26	4.66 ± 1.71
Medium	9	5.56 ± 2.30
Low		5.90 ± 2.51
Anxiety and depression degree			0.033
Mild	20	4.72 ± 1.32
Moderate	29	5.50 ± 2.53
Severe	13	5.97 ± 2.85
Tumor staging			0.001
Stage I	25	4.34 ± 1.55
Stage II	14	5.64 ± 2.19
Stage III	13	5.82 ± 2.44
Stage IV	10	6.78 ± 3.13
Chemotherapy cycle			0.006
First cycle	23	4.09 ± 1.13
Second cycle	19	4.52 ± 1.40
Third cycle	11	5.72 ± 2.37
Fourth cycle	9	6.46 ± 3.50
Pain degree			0.004
Mild	15	4.54 ± 1.75
Moderate	37	5.48 ± 2.44
Severe	10	6.31 ± 3.47